ACA
PFE icon

Arsenal Capital Advisors’s Pfizer PFE Stock Holding History

Arsenal Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Sell
9,780
-846
-8% -$22.1K 0.14% 101
2026
Q1 		$298K Buy
10,626
+841
+9% +$22.4K 0.22% 78
2025
Q4 		$244K Buy
+9,785
New +$247K 0.17% 85

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arsenal Capital Advisors's PFE Position: Q2 2026 in Review

Arsenal Capital Advisors reduced its Pfizer (PFE) stake by 8% in Q2 2026, selling an estimated $22.1K and leaving 9,780 shares worth $235K. The position accounts for 0.14% of the portfolio, ranked #101.

Arsenal Capital Advisors first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $298K in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Arsenal Capital Advisors held 9,780 shares of Pfizer worth $235K as of Q2 2026.
  • Arsenal Capital Advisors sold 846 Pfizer shares in Q2 2026, an estimated $22.1K.
  • Pfizer made up 0.14% of Arsenal Capital Advisors's portfolio in Q2 2026, its #101 holding.
  • Arsenal Capital Advisors first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Arsenal Capital Advisors's Pfizer position peaked at $298K in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Arsenal Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.